With the launch of new a $15.5 million, five-year initiative, the National Cancer Institute is ramping up efforts to help identify potential cancer biomarkers in the form of complex carbohydrate structures attached to lipid and protein molecules, known as glycans. A total of seven independent Tumor Glycome Laboratories will focus on potential glycan biomarkers for breast, ovarian, pancreatic, and prostate cancers, to name just a few. The Glycome Laboratories are the primary component of the new trans-NIH Alliance of Glycobiologists for Detection of Cancer and Cancer Risk.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.